Year: 2019
Type: review
Abstract: Poly(ADP-ribosyl)ation (PARylation) is an important post-translational modification in which an ADP-ribose group is transferred to the target protein by poly(ADP-riboses) polymerases (PARPs). Since the discovery of poly-ADP-ribose (PAR) 50 years ago, its roles in cellular processes have been extensively explored. Although research initially focused on the functions of PAR and PARPs in DNA damage detection and repair, our understanding of the roles of PARPs in various nuclear and cytoplasmic processes, particularly in gene expression, has increased significantly. In this review, we discuss the current advances in understanding the roles of PARylation with a particular emphasis in gene expression through RNA biogenesis and processing. In addition to updating PARP's significance in transcriptional regulation, we specifically focus on how PARPs and PARylation affect gene expression, especially inflammation-related genes, at the post-transcriptional levels by modulating RNA processing and degrading. Increasing evidence suggests that PARP inhibition is a promising treatment for inflammation-related diseases besides conventional chemotherapy for cancer.
Authors: Yueshuang Ke, Jing Zhang, Xueping Lv, Xianlu Zeng, Xueqing Ba
Institutions: Northeast Normal University, Wenzhou University
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: poly(ADP-ribosyl)ation, poly(ADP-ribose) polymerase, poly(ADP-ribose), post-translational modification, RNA metabolism, RNA biogenesis, RNA processing, RNA degradation, transcriptional regulation, post-transcriptional regulation, inflammatory genes, PARP inhibition, inflammation-related diseases, cancer chemotherapy
Open Access status: hybrid
Estimated APC paid: $3,760
OpenAlex ID: W2944182984
